Dr. Fernanda Artemisa Espinoza Hernández is a biologist who graduated from the Faculty of Sciences at UNAM (2014). She completed a Master’s degree in Biological Sciences with a focus on experimental biology (2017) and a PhD in Sciences (2022) in the Postgraduate Program in Biological Sciences at UNAM. Her areas of specialization are Ethnopharmacology, Biochemistry, Cell Biology, and Pathophysiology of Type 2 Diabetes. She has focused on the study of the mechanisms of action of medicinal plants traditionally used to treat diabetes, relating important aspects of their use and consumption with their therapeutic effect on relevant targets in the pathophysiology of the disease. Her skills include the generation of animal models of type 2 diabetes, the performance of in vitro enzymatic assays and biochemical tests for the determination of metabolic parameters, as well as the planning of experiments for the evaluation of plant extracts and molecules of pharmacological interest on targets involved in the development of type 2 diabetes. Since August 2025, she is part of the Biological Assays Laboratory of the Chemistry Institute at UNAM as an Academic Technician.
Dr. Fernanda Artemisa Espinoza Hernández is a biologist who graduated from the Faculty of Sciences at UNAM (2014). She completed a Master’s degree in Biological Sciences with a focus on experimental biology (2017) and a PhD in Sciences (2022) in the Postgraduate Program in Biological Sciences at UNAM. Her areas of specialization are Ethnopharmacology, Biochemistry, Cell Biology, and Pathophysiology of Type 2 Diabetes. She has focused on the study of the mechanisms of action of medicinal plants traditionally used to treat diabetes, relating important aspects of their use and consumption with their therapeutic effect on relevant targets in the pathophysiology of the disease. Her skills include the generation of animal models of type 2 diabetes, the performance of in vitro enzymatic assays and biochemical tests for the determination of metabolic parameters, as well as the planning of experiments for the evaluation of plant extracts and molecules of pharmacological interest on targets involved in the development of type 2 diabetes. Since August 2025, she is part of the Biological Assays Laboratory of the Chemistry Institute at UNAM as an Academic Technician.